MiMedx Group, Inc.MDXGNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank21
5Y CAGR-12.7%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

5Y CAGR
-12.7%/yr
Long-term compound
Percentile
P21
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
202511.79%
2024147.24%
2023249.64%
2022-802.77%
202193.45%
202023.21%
2019-210.10%
2018-43.13%
2017143.69%
201637.33%